4
460
J . Org. Chem. 2000, 65, 4460-4463
A On e-Step Syn th esis of
Sch em e 1
2
-(2-P yr id yl)-3H-in d ol-3-on e N-Oxid e: Is It
a n Efficien t Sp in Tr a p for Hyd r oxyl
Ra d ica l?
Gerald M. Rosen,*, Pei Tsai, Eugene D. Barth,
†,‡
†
§
|
|
|
Gilbert Dorey, Patrick Casara, Michael Spedding, and
Howard J . Halpern§
Department of Pharmaceutical Sciences, University of
Maryland School of Pharmacy, Baltimore, Maryland 21201,
Medical Biotechnology Center, University of Maryland
Biotechnology Institute, Baltimore, Maryland 21201,
Department of Radiation and Cellular Oncology, University
of Chicago, Illinois 60637, and Institute de Recherche
Servier, Croissy sur Seine 7829, France
Sch em e 2
Received April 20, 2000
The field of free radicals in biology has its origins in a
series of publications in the late 1960s in which the
•
-
secretion of superoxide (O
2
) during the enzymic cycling
1
7
of xanthine oxidase was first described. Soon thereafter,
a publication caught our fancy in which 2-(2-pyridyl)-
3H-indol-3-one N-oxide 4 was reported to spin trap HO .
•
a Cu/Zn-containing enzyme was found to disproportionate
2
this free radical into O
2
and H
2
O
2
. This enzyme, which
The corresponding spin trapped adduct, 2-hydroxy-2-(2-
pyridyl)-3H-indol-3-on-1-oxyl (11), exhibited remarkable
stability when compared to the shorter lifetime of 3-hy-
became known as superoxide dismutase (SOD), has
played a pivotal role in defining the ubiquitous nature
•
-
•- 3
7
of O
2
and other free radicals generated from O
2
.
droxy-5,5-dimethyl-1-pyrrolin-1-oxyl (13). However, en-
In the intervening years, a variety of methods have
been developed to detect free radicals in biological milieu.
Of those, spin trapping/EPR spectroscopy is singular in
its ability to characterize specific free radicals, generated
thusiasm for such robustness must be tempered by the
fact that 4, by lacking a hydrogen atom at the R-carbon,
has lost one of the strengths of spin trapping, additional
hyperfine splittings that can aid in the characterization
of the parent free radical.8 Despite this, there are a
number of experimental paradigms that would greatly
benefit from readily available sources of 2-aryl-3H-indol-
3-one N-oxides.
4
in situ, and identified in animal models in real time.
•
Based on our earlier success at identifying HO in
5
irradiated leg tumors of mice, we have become particu-
larly interested in syntheses of newer spin traps that
•
would allow the in vivo in situ detection of HO under
There have been a number of synthetic approaches to
other experimental paradigms. During the course of our
investigations, we have studied the specificity of 3-sub-
stituted 5,5-dimethyl-1-pyrroline N-oxides and a number
2
3
2
-aryl-3H-indol-3-one N-oxides, including 2-(2-pyridyl)-
H-indol-3-one N-oxide (see, for instance, Schemes 1 and
). However, multistep pathways, especially those in
•
6
of imidazoline N-oxides toward HO . Recently, however,
which intermediates are exposed to sunlight to obtain
the desired product, have often resulted in poor yields of
*
To whom correspondence should be addressed at the University
of Maryland School of Pharmacy. Tel: 410-706-0514. Fax: 410-706-
184.
the coveted nitrone.9
8
We thought, based on the earlier work of Castro and
†
10a
10b
University of Maryland School of Pharmacy.
University of Maryland Biotechnology Institute.
University of Chicago.
Stephens
and Sonogashira et al., that it might be
‡
§
|
possible to adapt these methods to the synthesis of the
title compounds. To our surprise, we were able to
synthesize a family of 2-aryl-3H-indol-3-one N-oxide in
a one-step reaction in excellent yields. Herein, we de-
scribed our preparative design.
Institute de Recherche Servier.
(1) McCord, J . M.; Fridovich, I. J . Biol. Chem. 1968, 243, 5753.
(2) McCord, J . M.; Fridovich, I. J . Biol. Chem. 1969, 244, 6049.
(3) (a) Fridovich, I. Science, 1978, 201, 875. (b) Fridovich, I. In
Superoxide Dismutase; Oberley, L. W., Ed.; CRC Press: Boca Raton,
FL, 1982; Vol. I, p 79. (c) Fridovich, I. Annu. Rev. Biochem. 1995, 64,
9
7. (d) Fridovich, I. J . Biol. Chem. 1997, 272, 18515.
4) (a) J anzen, E. G. Acc. Chem. Res. 1971, 4, 31. (b) Pou, S.;
Halpern, H. J .; Tsai, P.; Rosen, G. M. Acc. Chem. Res. 1999, 32, 2,
55.
5) Halpern, H. J .; Yu, C.; Barth, E.; Peric, M.; Rosen, G. M. Proc.
Natl. Acad. Sci. U.S.A. 1995, 92, 796.
6) (a) Rosen, G. M.; Turner, M. J ., III. J . Med. Chem. 1988, 31,
28. (b) Arya, P.; Stephens, J . C.; Griller, D.; Pou, S.; Ramos, C. L.;
(
(7) Nepveu, F.; Souchard, J .-P.; Rolland, Y.; Dorey, G.; Spedding,
M. Biochem. Biophys. Res. Commun. 1998, 242, 272.
1
(8) (a) J anzen, E. G.; Liu, J . I.-P. J . Magn. Reson. 1973, 9, 510. (b)
J anzen, E. G.; Evans, C. A.; Liu, J . I.-P. J . Magn. Reson. 1973, 9, 513.
(c) Buettner, G. R. Free Radical Biol. Med. 1987, 3, 259.
(9) (a) Ruggli, P.; Cuenin, H. Helv. Chim. Acta 1944, 27, 649. (b)
Kr o¨ hnke, F.; Vogt, I. Chem. Ber. 1952, 85, 376. (c) Bond, C. C.; Hooper,
M. J . Chem. Soc. C 1969, 2453. (d) Bond, C. C.; Hooper, M. Synthesis
1974, 443. (e) Bristow, T. H. C.; Foster, H. E.; Hooper, M., J . Chem.
Soc., Chem. Commun. 1974, 677.
(
(
4
Pou, W. S.; Rosen, G. M. J . Org. Chem. 1992, 57, 2297. (c) Kirilyuk, I.
A.; Grigor’ev, I. A.; Volodarskii, L. B. Bull. Acad. Sci. USSR 1992, 40,
1
871. (d) Haseloff, R. F.; Kirilyuk, I. A.; Dikalov, S. I.; Khramstov, V.
V.; Utepbergenov, D. I.; Blasig, I. E.; Grigor’ev, I. A. Free Radical Res.
997, 26, 159. (e) Tsai, P.; Pou, S.; Straus, R.; Rosen, G. M. J . Chem.
Soc., Perkin Trans. 2 1999, 1759.
(10) (a) Castro; C. E.; Stephens, R. D. J . Org. Chem. 1963, 28, 2163.
(b) Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahderon Lett. 1975,
4470.
1
1
0.1021/jo0006122 CCC: $19.00 © 2000 American Chemical Society
Published on Web 06/10/2000